Study explores whether a bidirectional causal link exists between MASLD and sarcopenia
Background and aims Metabolic dysfunction-associated steatotic liver disease (MASLD) and sarcopenia frequently coexist, yet their causal relationship and…
A young cancer patient and his family worry as NYC nurses’ strike continues
PORT WASHINGTON, N.Y. (AP) — When thousands of New York City nurses walked off the job last month…
New study identifies the optimal exercise dose for reducing hepatic steatosis
Hepatic steatosis is a core pathological feature of metabolic dysfunction-associated steatotic liver disease (MASLD). It not only drives…
Preclinical study reveals potential new treatment for severe liver fibrosis
Researchers at McMaster University are leading preclinical studies into a novel drug candidate developed by Espervita Therapeutics that has the potential to prevent and reverse liver fibrosis – a dangerous, disease-induced build-up of…
Rush University Medical Center’s Dr. Steven Flamm talks alcohol use, liver disease, impact of drinking ahead of new year
CHICAGO (WLS) — As a new year approaches, many people are rethinking their habits, including how much alcohol…
Sugar alcohol sorbitol may increase the risk of developing steatotic liver disease
Sweeteners such as aspartame, found in Equal packets, sucralose (Splenda), or sugar alcohols are often seen as healthier…
Alternative sweetener linked to liver disease
Share this Article You are free to share this article under the Attribution 4.0 International license. Researchers have…
Combined healthy eating and exercise linked to greater reductions in visceral fat
Improving diet and increasing physical activity levels together may be more effective at preventing weight gain – particularly…
Blood group A linked to a higher risk of primary biliary cholangitis
A major retrospective study shows that people with blood group A face a higher likelihood of autoimmune liver…
Hepatologist shares which foods and drinks you should restrict, completely avoid or consume to reduce fatty liver risk
The World Health Organisation (WHO) data published on Sciencedirect.com in April 2024 shows the growing burden of liver…
Prevalence of Hepatitis E genotype 3 among liver disease patients in Southwestern Nigeria | Virology Journal
Stanaway JD, Flaxman AD, Naghavi M, Fitzmaurice C, Vos T, Abubakar I, et al. The global burden of…
GLP-1 goliath updates demand for top weight loss drug
Novo Nordisk reported Q3 2025 earnings on November 5, showing continued strong demand for its weight-loss drug Wegovy,…